It was reported that spa can activate the NF-κB pathway [42,43], and some studies associated aggressive CTCL with upregulated NF-κB signalling [44,45,46]. The gene discussed is NFKB1; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.